Research chemical β not approvedaka Larazotide acetate, AT-1001, INN-202
Larazotide β Complete Research Guide (2026)
Last updated 2026-06-25
An investigational peptide studied as a tight-junction regulator for celiac disease in human clinical trials; not approved.
Full sourced guide in progress
We publish a complete, primary-source-cited guide only once we can verify at least five PubMed/clinical references. This profile is intentionally a stub until then β we do not pad pages with unverified citations. The quick facts above reflect what we can state reliably today.
Related peptides
This article is for educational and research purposes only. Peptides discussed here are not approved for human consumption by the FDA, EMA, or equivalent regulators outside of specific clinical contexts. Always consult a licensed medical professional before any therapeutic use.